Cargando…

Evaluator-blinded trial evaluating nurse-led immunotherapy DEcision Coaching In persons with relapsing-remitting Multiple Sclerosis (DECIMS) and accompanying process evaluation: study protocol for a cluster randomised controlled trial

BACKGROUND: Multiple sclerosis is a chronic neurological condition usually starting in early adulthood and regularly leading to severe disability. Immunotherapy options are growing in number and complexity, while costs of treatments are high and adherence rates remain low. Therefore, treatment decis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rahn, Anne Christin, Köpke, Sascha, Kasper, Jürgen, Vettorazzi, Eik, Mühlhauser, Ingrid, Heesen, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397890/ https://www.ncbi.nlm.nih.gov/pubmed/25872529 http://dx.doi.org/10.1186/s13063-015-0611-7

Ejemplares similares

Evaluation of an interactive web-based programme on relapse management for people with multiple sclerosis (POWER@MS2): study protocol for a process evaluation accompanying a randomised controlled trial
por: Wenzel, Lisa, et al.
Publicado: (2021)

Risk knowledge of people with relapsing-remitting multiple sclerosis – Results of an international survey
por: Giordano, Andrea, et al.
Publicado: (2018)

Why not? – Communicating stochastic information by use of unsorted frequency pictograms – a randomised controlled trial
por: Kasper, Jürgen, et al.
Publicado: (2011)

Development and evaluation of an interactive web-based decision-making programme on relapse management for people with multiple sclerosis (POWER@MS2)—study protocol for a randomised controlled trial
por: Rahn, Anne Christin, et al.
Publicado: (2021)

Correction to: Development and evaluation of an interactive web-based decision-making programme on relapse management for people with multiple sclerosis (POWER@MS2)—study protocol for a randomised controlled trial
por: Rahn, Anne Christin, et al.
Publicado: (2021)

Short-term interval aerobic exercise training does not improve memory functioning in relapsing-remitting multiple sclerosis—a randomized controlled trial
por: Baquet, Lisa, et al.
Publicado: (2018)

Immunotherapy for people with clinically isolated syndrome or relapsing-remitting multiple sclerosis: treatment response by demographic, clinical, and biomarker subgroups (PROMISE)—a systematic review protocol
por: Lehnert, Thomas, et al.
Publicado: (2022)

Comprehension of confidence intervals - development and piloting of patient information materials for people with multiple sclerosis: qualitative study and pilot randomised controlled trial
por: Rahn, Anne C., et al.
Publicado: (2016)

Assessing the effect of an evidence-based patient online educational tool for people with multiple sclerosis called UMIMS—understanding magnetic resonance imaging in multiple sclerosis: study protocol for a double-blind, randomized controlled trial
por: Schiffmann, Insa, et al.
Publicado: (2020)

Evaluation of an evidence-based guidance on the reduction of physical restraints in nursing homes: a cluster-randomised controlled trial [ISRCTN34974819]
por: Haut, Antonie, et al.
Publicado: (2009)

A new graphical format to communicate treatment effects to patients—A web‐based randomized controlled trial
por: Kasper, Jürgen, et al.
Publicado: (2016)

Quality of Stroke Patient Information Applied in Randomized Controlled Trials—Literature Review
por: Alegiani, Anna C., et al.
Publicado: (2020)

An interactive web-based programme on relapse management for people with multiple sclerosis (POWER@MS2) - development, feasibility, and pilot testing of a complex intervention
por: Wenzel, Lisa, et al.
Publicado: (2022)

Impact of a multimedia website with patient experiences of multiple sclerosis (PExMS) on immunotherapy decision-making: study protocol for a pilot randomised controlled trial in a mixed-methods design
por: Barabasch, Anna, et al.
Publicado: (2021)

Epigallocatechin Gallate in Relapsing-Remitting Multiple Sclerosis: A Randomized, Placebo-Controlled Trial
por: Bellmann-Strobl, Judith, et al.
Publicado: (2021)

Reasons for delayed admission after stroke: results of a qualitative and quantitative survey
por: Alegiani, Anna Christina, et al.
Publicado: (2019)

The Decimal Association
por: Johnson, E.
Publicado: (1905)

Decimal Arrangement
Publicado: (1881)

A non-randomized clinical trial to evaluate the effect of fingolimod on expanded disability status scale score and number of relapses in relapsing-remitting multiple sclerosis patients
por: Mazdeh, Mehrdokht, et al.
Publicado: (2019)

Evaluating sex hormones and cytokine profile in Egyptian females with relapsing-remitting multiple sclerosis
por: Talaat, Forayssa M., et al.
Publicado: (2018)

Randomized control trial evaluation of a modified Paleolithic dietary intervention in the treatment of relapsing-remitting multiple sclerosis: a pilot study
por: Irish, Amanda K, et al.
Publicado: (2017)

Cholecalciferol in relapsing-remitting MS: A randomized clinical trial (CHOLINE)
por: Camu, William, et al.
Publicado: (2019)

Predicting the risk of falling – efficacy of a risk assessment tool compared to nurses' judgement: a cluster-randomised controlled trial [ISRCTN37794278]
por: Meyer, Gabriele, et al.
Publicado: (2005)

Universal decimal classification
por: British Standards Institution. London
Publicado: (1993)

Universal decimal classification
por: British Standards Institution. London
Publicado: (1961)

Decimal memory systems
por: Maeder, D
Publicado: (1958)

The Decimal System of Notation
por: Brownell, T. F.
Publicado: (1878)

Rituximab for the treatment of relapsing-remitting multiple sclerosis in Thailand: an economic evaluation and budget impact analysis
por: Aungsumart, Saharat, et al.
Publicado: (2023)

Implementation of shared decision-making in oncology: development and pilot study of a nurse-led decision-coaching programme for women with ductal carcinoma in situ
por: Berger-Höger, Birte, et al.
Publicado: (2017)

In silico clinical trials for relapsing-remitting multiple sclerosis with MS TreatSim
por: Sips, Fianne L. P., et al.
Publicado: (2022)

Magnetic Resonance Imaging in Multiple Sclerosis – Patients' Experiences, Information Interests and Responses to an Education Programme
por: Brand, Judith, et al.
Publicado: (2014)

Decimal classification of CAMAC instrumentation
por: Nicolaysen, O P
Publicado: (1973)

Clinical and economic evaluations of natalizumab, rituximab, and ocrelizumab for the management of relapsing-remitting multiple sclerosis in Saudi Arabia
por: Alharbi, Mansour A., et al.
Publicado: (2023)

Emerging Methods for Evaluating the Effectiveness of Intramuscular Interferon Beta-1a for Relapsing-Remitting Multiple Sclerosis
por: Foley, John F., et al.
Publicado: (2013)

Lipid Mediator Profiles Predict Response to Therapy with an Oral Frankincense Extract in Relapsing-Remitting Multiple Sclerosis
por: Stürner, Klarissa Hanja, et al.
Publicado: (2020)

A double‐blind, randomized, placebo‐controlled phase 2 trial evaluating the selective dihydroorotate dehydrogenase inhibitor vidofludimus calcium in relapsing‐remitting multiple sclerosis
por: Fox, Robert J., et al.
Publicado: (2022)

Oral ponesimod in relapsing–remitting multiple sclerosis: a randomised phase II trial
por: Olsson, Tomas, et al.
Publicado: (2014)

Functional and structural connectivity substrates of cognitive performance in relapsing remitting multiple sclerosis with mild disability
por: Has Silemek, Arzu Ceylan, et al.
Publicado: (2020)

Causal interpretation of correlational studies – Analysis of medical news on the website of the official journal for German physicians
por: Buhse, Susanne, et al.
Publicado: (2018)

Guide to use of Dewey decimal classification : based on the practice of the Decimal classification Office at the Library of Congress
Publicado: (1962)

Cannot write session to /tmp/vufind_sessions/sess_g0d15vivjl7nbd8n2imc5922e7